Trademark: 98089376
Word
IMMUNOVX
Status
Pending
Status Code
641
Status Date
Saturday, March 23, 2024
Serial Number
98089376
Mark Type
4
Filing Date
Tuesday, July 18, 2023

Trademark Owner History

Classifications
42 Clinical research in the field of pharmaceutical, biologic, biotechnology, vaccine, infectious disease treatment, and adjuvant research and development; Research and development and consultation related thereto in the field of pharmaceutical, biologic, biotechnology, vaccine, infectious disease treatment, and adjuvant research and development; Research and development in the field of pharmaceutical, biologic, biotechnology, vaccine, infectious disease treatment, and adjuvant research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of new products for others; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific research; Scientific research consulting; Scientific research consulting in the field of pharmaceutical, biologic, biotechnology, vaccine, infectious disease treatment, and adjuvant research and development; Basic and clinical research in the field of respiratory science and medicine; Biochemical research and development; Consulting services for others in the field of design, planning, and implementation project management of pharmaceutical, biologic, biotechnology, vaccine, infectious disease treatment, and adjuvant research and development; Medical and scientific research in the field of pharmaceutical, biologic, biotechnology, vaccine, infectious disease treatment, and adjuvant research and development; Medical and scientific research information in the field of pharmaceutical, biologic, biotechnology, vaccine, infectious disease treatment, and adjuvant research and development; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical research and development; Product research and development; Providing information about medical research in the field of pharmaceutical, biologic, biotechnology, vaccine, infectious disease treatment, and adjuvant research and development; Providing information about medical and scientific research; Providing medical and scientific research information; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research and development; Scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical, biologic, biotechnology, vaccine, infectious disease treatment, and adjuvant research and development; Scientific study and research in the field of reproduction, husbandry, and general health of food-chain animals; Vaccine research and development; Vaccine research and development services

Trademark Events
Jul 21, 2023
New Application Entered
May 10, 2024
Teas Response To Office Action Received
Mar 23, 2024
Notification Of Non-Final Action E-Mailed
Aug 16, 2023
New Application Office Supplied Data Entered
Mar 23, 2024
Assigned To Examiner
Mar 23, 2024
Non-Final Action Written
Mar 23, 2024
Non-Final Action E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24